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Мета роботи: масштабування лабораторної методики синтезу 4-метоксіаніліду 5-(4-метил- 
феніламінометил-4-(2-метилфеніл)-1,2,4-триазол-4Н-3-ілтіооцтової кислоти (Тріазопразола) для 
відтворення в промислових умовах. 
Методи. При розробці промислової технології оцінювали ефективність синтезу (виходи на кожній 
стадії синтезу, можливість проведення синтезу без виділення напівпродуктів), відповідність принципам 
зеленої хімії та економічну доцільність. Відповідно до концепції Quality by design, принципами зеленої 
хімії і розробленими раніше алгоритмами для оптимізації промислового синтезу проаналізовано 
теоретичні можливості проведення синтезу в промислових умовах. Оптимальні умови проведення 
реакцій визначені експериментально. 
Результати. В результаті проведених експериментальних досліджень доведено можливість синтезу 
ключового інтермедіату – 5-метилфеніламінометил-4-(2-метилфеніл)-1,2,4-триазол-3-тіону - без 
виділення проміжного продукту, що дозволило збільшити його вихід в перерахунку на вихідні речовини . 
Скорочено час проведення окремих стадій синтезу, при цьому вихід і чистота продуктів залишається 
задовільною. Для алкілування ключового інтермедіату оптимальними умовами обрані температура 
реакції - 70 °С, час – 1 година, використання системи ДМФА-луг. Такі умови дозволяють забезпечити 
високий вихід і чистоту кінцевого продукту. 
Висновки Здійснено масштабування методики синтезу потенційного АФІ з противиразковою дією 4-
метоксіаніліда 5- (4-метілфеніламінометіл-4-(2-метилфеніл)-1,2,4-триазол-4Н-3-ілтіооцтової кислоти 
для відтворення в умовах промислового виробництва з використанням концепції Quality by design та 
принципів «зеленої хімії». Скорочено кількість стадій синтезу. Підібрано умови, в яких цільовий продукт 
утворюється з максимальним виходом і прийнятною чистотою 
Ключові слова: активний фармацевтичний інгредієнт, промисловий синтез, масштабування, зелена 
хімія, похідні 1,2,4-триазолу, противиразкові засоби 
 
1. Introduction 
1,2,4-Triazoles are substances that have begun to 
be widely introduced into pharmaceutical practice in 
recent times. Among them, substances that have different 
types of pharmacological activity were found. The most 
famous of them are Ukrainian brand thiotriazoline [1, 2], 
ribavirin, thiamazole, fluconazole, itraconazole and oth-
ers [3]. The attractiveness of this class of compounds is 
also due to the fact that the synthesis of the starting mate-
rials is fairly simple and allows the introduction of vari-
ous substituents into the free positions of the heterocyclic 
ring during the cyclization stage. 
 
2. Formation of the problem in a general way, 
the relevance of the theme and its connection with 
important scientific and practical issues 
We previously planned and carried out the synthe-
sis of biologically active substances in the series of aryl 
(alkyl) amides of 4,5-disubstituted 1,2,4-triazol-4H-3-
ylthioacetic acids [4, 5]. Among the compounds synthe-
sized substances with a high level of antiulcer, anticon-
vulsant and antitumor activity were found [4, 6]. The 
most active substances were patented. At present, some 
of them are included into the research plans of some 
pharmaceutical enterprises in Ukraine and Tajikistan. 
To conduct in-depth studies on preclinical re-
search, as well as pharmaceutical development, it is nec-
essary to scale-up the laboratory synthesis procedure and 
develop an industrial technology for the synthesis of a 
potential APIs. 
 
3. Analysis of recent studies and publications in 
which a solution of the problem is described and to 
which author refers 
Earlier, scientists of the National Pharmaceutical 
University proposed approaches to this kind of develop-
ment [7]. Based on this, we took into account that the 
peculiarity of the synthesis of API in industrial condi-
tions is the need to ensure not only high yields of the 
final product, but also acceptable purity within the re-
quirements of the European Pharmacopoeia. For this, it is 
necessary to minimize the number of synthesis steps, to 
develop an optimal procedure for purification from start-
ing materials and intermediates, and to prevent the occur-
rence of side processes. In addition, we have tried to take 
into account the principles of "green chemistry" to ensure 
safe production for personnel and the environment. 
 
4. The field of research considering the general 
problem, which is described in the article 
Based on the results of the pharmacological 
screening, a prospective anti-ulcer API-4-methoxyanilide 
of 5-(4-methylphenylaminomethyl)-4-(2-methylphenyl)-
1,2,4-triazol-4H-3-ylthioacetic acid (1) with high level of 
activity in the screening experiment was identified [5]: 
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This compound was planned for in-depth preclini-
cal studies and the pharmaceutical development of a 
dosage form under the conventional name Triazoprazole. 
 
5. Formulation of goals (tasks) of article 
The aim of this study is to scale-up the laboratory 
procedure for the synthesis of 4-methoxyanilide 5-(4-
methylphenylaminomethyl)-4-(2-methylphenyl)-1,2,4-
triazol-4H-3-ylthioacetic acid (Triazoprazole) for repro-
ducing and operating in industrial conditions. 
 
6. Presenation of the main research material 
(methods and objects) with the justification of the 
results 
Under laboratory conditions, the synthesis of this 
substance was carried out in three stages:  
Synthesis of 5-(4-methylphenylaminomethyl)-4-
(2-methylphenyl)-1,2,4-triazol-3-thione (intermediate 1); 
Synthesis of 4-methoxyphenylamide of chloroace-
tic acid (intermediate 2); 
Interaction of intermediates 1,2 lead to the end-
product 4-methoxyanilide of 5- (4-methylphenylamino- 
methyl)-4-(2-methylphenyl)-1,2,4-triazol-4H-3-ylthioacetic 
acid [5]. 
Based on the analysis of literature data [8–10], 
this method that is an optimal and perhaps the only pos-
sible for the formation of a 1,2,4-triazole ring containing 
a thiol group in the 3rd position, 2-methylphenyl moiety 
in 4th position and a 4-methylphenylaminomethylene 
fragment in 5th. 
Scheme synthesis of the potential API is fairly 
simple, does not require special synthetic techniques and 
using of toxic solvents. We carried out a preliminary 
evaluation of pharmaceutical development using the 
method proposed by the scientists of the National Uni-
versity of Pharmacy [7, 11]. 
When developing the industrial technology, we 
took into account several different factors: the efficiency 
of the synthesis (the yields at each stage of the synthesis, 
the possibility of carrying out the synthesis without sepa-
rating the intermediates). We also studied correspond-
ence to the green chemistry principles [12], the possibil-
ity of obtaining synthetic intermediates from the chemi-
cal manufacturers and the economic feasibility. In ac-
cordance with the algorithm proposed earlier Pharmaceu-
tical development of industrial synthesis of APIs should 
be given priority to the acquisition of reagents, and not to 
their synthesis. Important was also a comparison of the 
toxic properties of the starting materials. 
In accordance with the Quality by design concept 
and the algorithms developed earlier [7, 11], the first 
stage to optimize industrial synthesis was analysis of the 
theoretical possibilities for carrying out of chemical reac-
tions. For implementation into industrial production, we 
considered each stage separately. 
According to the synthesis scheme (Fig. 1)  
4-toluidine (2) is used as the starting substance to prepare 
the intermediate 1, which is alkylated with chloroacetic 
acid ethyl ester. The resulting  
4-methylphenylaminoacetic acid ethyl ester (3) is con-
verted into hydrazide (4) by the action of hydrazine hy-
drate.  
When the hydrazide reacts with 2-methylphenyl 
isothiocyanate (5), an appropriate thiosemicarbazide (6) 
is formed, the cyclization of which leads to the key in-
termediate (7) usually existing in two tautomeric forms. 
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Fig. 1. Scheme of the synthesis of 5-(4-methylphenylaminomethyl)-4-(2-methylphenyl)-1,2,4-triazol-3-thione (step 1) 
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We analyzed the list of possible reagents for synthe-
sis at this stage. Thus, to obtain hydrazides with high yields, 
the interaction of hydrazine hydrate with esters is an optimal 
[13]. These reactions proceed easily and are characterized 
by high yields even without heating. The use of acids as 
starting substance in this case is impossible, and the use of 
acid chloranhydrides can lead to the production of a sym-
metric hydrazides. Therefore, the use of chloroacetic acid 
ethyl ester as a starting material in the reaction is theoretical-
ly justified and does not require additional experimental 
justification. It should be noted that p-toluidine, like most 
anilines, is toxic and its use in the company requires certain 
protective measures for personnel [14]. 
The following issues were subject to discussion: 
– Commercial availability of intermediates – 2-(4-
methylphenyl)aminoacetic acid hydrazide, 2-methyl- 
phenyl isothiocyanate. In the absence of those, the opti-
mal acylating agent for the synthesis of hydrazide and, 
accordingly, the starting material for the alkylation of 
aniline in the 1st stage. 
– Solvent in the alkylation step and optimum pro-
cess conditions 
– Optimal conditions for obtaining hydrazide de-
pending on the choice of the starting material at the 1st 
stage. 
– Conditions for obtaining thiosemicarbazide 6. 
Optimal cyclization conditions for the production of 
triazole 7.  
– Possibility of one pot synthesis without separa-
tion of intermediate products. Prevention of impurities 
formation. 
4-Methylphenylaminoacetylhydrazide (4) is pre-
sent on the market of chemical substances. This allows to 
reduce the first two stages – synthesis of ethyl 4-
methoxyphenylaminoacetate and its hydrazinolysis. The 
substances are offered by the Ukrainian (Enamin and 
Orgsintez), American (Ryan Scientific, Inc), Spanish 
(Santa Cruz Biotechnology), as well as Chinese (Hang-
zhou J & H Chemical Co., Ltd) and many other interna-
tional manufacturers and implementers. Therefore, it is 
expedient to purchase this intermediate product instead 
of two stages of synthesis at the enterprise. In addition, 
this avoids the use of toxic toluidine 2 during production. 
Thus, the synthesis of the first key intermediate, 
5-(4-methylphenylaminomethyl)-4-(2-methylphenyl)-
1,2,4-triazole-3-thione 7, is supposed to be carried out in 
two stages – the interaction of 4-methylphenyl- 
aminoacetyl hydrazide with 2-methylphenyl isothiocya-
nate and subsequent cyclization of the thiosemicarbazide 
6 into correspondent triazole 7. As a result of the experi-
mental study, it was found that in the first stage, after 1 
hour of the reaction mass boiling, impurities of the initial 
substances still remain in it, while after 1.5 hours a 
chromatographic plate only spot thiosemicarbazide is 
observed and there no spot of the starting materials. 
Therefore, we extended the stage of interaction of hydra-
zide with thiosemicarbazide up to 1.5 hours (Table 1).  
In laboratory synthesis, we isolated the thiosemi-
carbazide formed from the reaction mixture [5]. The high 
yield of thiosemicarbazide and the absence of possible side 
reactions, as well as the absence of a significant amount of 
impurities of the starting materials, became a prerequisite 
for the possibility of carrying out the synthesis without 
isolation of the intermediate thiosemicarbazide. 
Previously, it was necessary to establish the opti-
mal time for cyclization of thiosemicarbazide into the 
key triazole thione 7. Evaluation of the completeness of 
the synthesis was carried out by the yield of the key in-
termediate, and the purity of the resulting intermediate by 
the TLC method (Table 2). 
 
Table 1 
The effect of solvent and temperature on yield and purity of the thiosemicarbazide 6 
 Solvent Time, min Yield, % Impurities (ТLC)* 
1 ethanol 60 55 +++ 
2 70 64 ++ 
3 80 67 + 
4 90 81 _** 
5 methanol 60 57 +++ 
6 70 64 ++ 
7 80 68 + 
8 90 82 –** 
9 acetonitrile 60 57 +++ 
10 70 65 ++ 
11 80 67 + 
12 90 84 –** 
Note: * – Visual evaluation of the spot fluorescence intensity in UV light; ** – On the chromatographic plate, traces at the level of 
the spots of starting materials 
 
Table 2 
The effect of the time on the 5-(4-methylphenylaminomethyl)-4-(2-methylphenyl)-1,2,4-triazole-3-thione yield 
 Time Yield, % Impurities*  Time Yield, % Impurities* 
1 210 59 ++ 4 300 76 + 
2 240 68 ++ 5 330 78 + 
3 270 75 + 6 360 78 + 
Note: * – Visual evaluation of the spot fluorescence intensity in UV light 
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Experimental studies have established that satis-
factory yield and purity of key intermediate can be 
achieved after 270 minutes of synthesis. Further, the 
yield grows insignificantly. Therefore, it was decided to 
shorten the synthesis time at this stage to 4.5 hours in-
stead of 5, during which the synthesis was previously 
performed in laboratory synthesis [5]. 
To carry out the synthesis without isolation of thi-
osemicarbazide, after completion of the first stage of the 
synthesis, distillation of ethyl alcohol under vacuum was 
carried out. To the wet, dry residue, after distilling off the 
alcohol, water was added and the precipitate was sus-
pended, and then alkali was added for cyclization. As 
shown by the results of the experiment, the yield of 5-(4-
methylphenylaminomethyl)-4-(2-methylphenyl)-1,2,4-
triazole-3-thione in terms of the initial hydrazide was 
expected to be greater (72 % vs. 61 %) as result of one-
pot synthesis due to the absence of losses, which are 
unavoidable during thiosemicarbazide isolation. The 
purity of the product was comparable at the same time. 
Synthesis procedures 
Method 1 – with the isolation of thiosemicarba-
zide. 1st stage. 149.2 g (1 Mol) of 4-methylphenyl isothi-
ocyanate are slowly added dropwise to a solution of 
199.6 g (1 Mol) of 4-methylphenylaminoacetylhydrazide 
3 in 1 L of ethanol with vigorous stirring. The reaction 
mixture was heated under reflux for 1.5 hours, cooled. 
The precipitate of the substituted thiosemicarbazide is 
filtered off and dried. Yield 266 g (81 %). 2nd stage. To a 
suspension of 266 g (0.81 Mol) of thiosemicarbazide 6 in 
1 liter of water, 90.7 g (1.62 Mol) of potassium hydrox-
ide was added. The reaction mixture was refluxed for 4.5 
hours. After cooling, the mixture is acidified with hydro-
chloric acid to pH 3-4. The precipitate of 5-(4-
methoxyphenylaminomethyl)-4-(2-methylphenyl)-1,2,4-
triazol-4H-3-thione is filtered off, washed with water and 
dried. The yield is 180.1 g (75 %, recalculating to the 
original hydrazide 60.8 %). 
Method 2 – without isolation of thiosemicarba-
zide. 149.2 g (1 Mol) of 2-methylphenyl isothiocyanate 
are slowly added to a solution of 199.6 g (1 Mol) of 4-
methylphenylaminoacetylhydrazide 3 in 1 L of ethanol 
with vigorous stirring. The reaction mixture was heated 
under reflux for 1.5 hours, cooled, alcohol (700 ml). was 
distilled under vacuum. 1 liter of water is added to the 
residue in the flask with stirring, the suspension is stirred 
for 10 minutes, then, while stirring is continued, 112 g  
(2 mol) of potassium hydroxide are gradually added. The 
reaction mixture was refluxed for 4.5 hours. After the 
end of reaction, the mixture is cooled, acidified with 
hydrochloric acid to pH 3-4. The precipitate of the 5-(4-
methylhenylaminomethyl)-4-(2-methylphenyl)-1,2,4-
triazol-4H-3-thione is filtered off, washed with water, 
and dried. Yield: 213.4 g (72 %). 
The next step in the synthesis is obtaining of the 
second intermediate, 4-methoxyanilide of chloroacetic 
acid. This synthesis is quite simple and involves the 
acylation of 4-methoxyaniline (4-anisidine) with chloro-
acetyl chloride. The use of chloroacetic acid or its esters 
for this purpose is irrational, since in this case an alkyla-
tion reaction of anisidine will predominantly take place 
and the main product of the reaction will be the phenyl-
aminoacetic acid derivative. Acid chloride purchase due 
to its instability and high price is irrational, and its pro-
duction is associated with the formation of volatile toxic 
products, which, in addition, can corrode equipment. 
Therefore, we studied the possibility of buying anilide. 
Manufacturers and distributors of chemical substances 
offer 4-methoxyanilide of chloroacetic acid. Its price is 
high enough. However, taking into account the difficul-
ties described above, coupled with its independent syn-
thesis, we gave priority to its acquisition. Thus, the num-
ber of synthesis steps is reduced by one more. 
The final step in the synthesis of the aim substance 
is alkylation. Synthesis of the desired product (1) is carried 
out by reacting the intermediates 7 and 8 (Fig. 2). 
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Fig. 2. Scheme of the synthesis of 4-methoxyanilide of 5-(4-methylphenylaminomethyl)-4-(2-methylphenyl)-1,2,4-
triazol-4H-3-ylthioacetic acid. 
 
 
Alkylation of the triazole-thione is possible due to 
thion-thiol tautometry, the stabilization of the thiol form 
occurs in an alkaline medium. Typically, the alkylation is 
carried out in an alcoholic medium in the presence of 
various basic catalysts. High yields can be achieved by 
using for this purpose an alcoholic solution of alkali or a 
superbasic medium – the DMF-crystalline alkali system 
or DMSO-potash. Since DMSO is heavily washed from 
the equipment and can generate toxic sulfur-containing 
substances under temperature influence, we conducted 
experimental studies for two systems. The effect of sol-
vents, time and temperature (during DMF using) was 
studied. As can be seen from Table 3, the best yields 
were achieved when using for the synthesis in the DMF-
alkali medium.  
We preferred preference for industrial synthesis at 
70° C, that is consistent with the principle of "green 
chemistry" on saving energy costs. 
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Table 3 
Effect of synthesis conditions on the yield and purity of the end product 
  Time, min Temperature Yield Impurities* 
1 
Alkali solution in alcohol 
30 
boiling 
65 ++ 
2 40 71 ++ 
3 50 84 + 
4 60 86 + 
5 70 87 + 
6 
DMF-alkali 
30 
70°C 72 ++ 
7 120°C 77 ++ 
8 
40 
70°C 86 ++ 
9 120°C 88 ++ 
10 
50 
70°C 92 + 
11 120°C 94 ++ 
12 
60 
70°C 93 + 
13 120°C 94 ++ 
Note: * – Visual evaluation of the spot fluorescence intensity in UV light 
 
Procedure of the synthesis of 4-methoxyanilide 5-
(4-methylphenylaminomethyl)-4-(2-methylphenyl)-
1,2,4-triazol-4H-3-ylthioacetic acid (1). To a solution of 
296.4 g (1 Mol) of mercaptotriazole 7 in 1000 ml etha-
nol, 1000 ml of an aqueous solution of 56 g (1 Mol) of 
KOH at stirring 1000 ml of an alcoholic solution of 200 g 
(1 Mol) of chloroacetic acid 4-metoxyanilide is added. 
The reaction mixture is heated at 70°C for 1 hour, than 
cooled, poured out into 3000 ml of water. The precipitate 
formed is washed with water and dried. Yield 440, 4 g 
(93 %) 
 
7. Conclusion from the conducted research and 
prospects for further development of this field 
Scaling of the method of synthesis of a potential 
API with the antiulcer action - 4-methoxyanilide of 5-(4-
methylphenylaminomethyl)-4-(2-methylphenyl)-1,2,4-
triazol-4H-3-ylthioacetic acid (Triazoprazol) for industri-
al production using the concept Quality by design and 
"green chemistry "was carried out. The number of stages 
of synthesis has been reduced and the conditions when 
the end product is formed with the maximum yield and 
acceptable purity are selected experimentally. 
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